Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0S4OH
|
|||
| Former ID |
DIB000101
|
|||
| Drug Name |
Anti-CD20 engineered toxin bodies
|
|||
| Synonyms |
Anti-CD20 engineered toxin bodies (lymphoma); Anti-CD20 ETBs (lymphoma), Molecular Templates; Anti-CD20 engineered toxin bodies (lymphoma), Molecular Templates
Click to Show/Hide
|
|||
| Indication | Lymphoma [ICD-11: 2A80-2A86; ICD-9: 202.8, 208.9] | Investigative | [1] | |
| Company |
Molecular Templates Inc
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Leukocyte surface antigen Leu-16 (CD20) | Target Info | Modulator | [1] |
| KEGG Pathway | Hematopoietic cell lineage | |||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Target id: 2628). | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.